Tin tức & Cập nhật

Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
18 Feb 2023

Several patients with nonsmall cell lung cancer (NSCLC) treated with nivolumab report developing immune-related adverse events (irAEs), primarily affecting the skin, lungs, and gastrointestinal system, according to a study.

Immune-mediated reactions predict survival in nivolumab-treated NSCLC patients
18 Feb 2023
Counselling, pamphlets boost flu vaccine intake in SG
Counselling, pamphlets boost flu vaccine intake in SG
17 Feb 2023
Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023

In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
15 Feb 2023

Treatment with intravitreal aflibercept in patients with nonproliferative diabetic retinopathy but without centre-involved diabetic macular edema appears to slow disease progression and reduce the risk of developing vision-threatening complications but fall short of improving visual acuity, according to a study.

Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
15 Feb 2023